Atlas Trials

Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Clinical trial NCT06026917 · UNKNOWN

Trial details

NCT number
NCT06026917
Sponsor
Shanghai Mental Health Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2023-09-25
Primary completion
2024-01-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.